Clinical trial
Comparison of Three Different Initial Treatments Without Protease Inhibitors for…
NCT00013520 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00013520 |
|---|---|
| Title | Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection |
| Official title | Phase III, Randomized, Double-Blind Comparison of Three Protease Inhibitor-Sparing Regimens for the Initial Treatment of HIV Infection |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Abacavir sulfate, Lamivudine and Zidovudine, Atazanavir, Lamivudine/Zidovudine, Efavirenz, Nevirapine, Lamivudine, Stavudine, Zidovudine, Didanosine |
| Enrollment | 1,125 |
| Completion | Jun 1, 2005 |
| First posted | Aug 31, 2001 |
| Last update posted | May 21, 2012 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: